HALOBETASOL PROPIONATE; TAZAROTENE | N209354 | BAUSCH HEALTH AMERICAS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH HEALTH IRELAND LIMITED et al v. TARO PHARMACEUTICALS INC. et al 4 patentsANDA 217190halobetasol propionate 0.01%; tazarotene 0.045% | D.N.J. | 2022-07-21 | Terminated 2024-04-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8809307 | Nov 2, 2031 | — | — | Yes | — | — |
| 10251895 | Jun 6, 2036 | — | — | Yes | — | — |
| 10426787 | Jun 6, 2036 | — | — | — | — | |
| 10478502 | Nov 2, 2031 | — | — | Yes | — | |
| 11648256 | Jun 6, 2036 | — | — | Yes | — | |
| 11679115 | Jun 6, 2036 | — | — | Yes | — | |
| 11839656 | Nov 2, 2031 | — | — | — | — | |
| 11957753 | Nov 2, 2031 | — | — | Yes | — | — |
| 11986527 | Nov 2, 2031 | — | — | — | — | |
| 12076403 | Nov 2, 2031 | — | — | Yes | — | — |